Aurinia Pharmaceuticals AUPH Revenue
Revenue at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's revenue?
- Aurinia Pharmaceuticals (AUPH) reported revenue of $77.71M in Q1 2026.
- How has Aurinia Pharmaceuticals's revenue changed year-over-year?
- Aurinia Pharmaceuticals's revenue increased by 24.4% year-over-year, from $62.47M to $77.71M.
- What is the long-term trend for Aurinia Pharmaceuticals's revenue?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's revenue has grown at a 57.8% compound annual growth rate (CAGR), from $45.61M to $283.06M.